Clinical trialNCT02781012UnknownObservational

Project Survival-Prospective Biomarker Discovery

SponsorPancreatic Cancer Research TeamEnrollment436Metastatic Pancreatic CancerPancreatic AdenocarcinomaPancreatic CancerPancreatic NeoplasmsPancreatitis

View the registry record on ClinicalTrials.gov

Summary

The lay summary the sponsor registered on ClinicalTrials.gov.

This sample-collection study is open to participants in several categories: healthy volunteers (with or without a family history of pancreatic cancer) and individuals diagnosed with pancreatitis or any stage of pancreatic cancer. All participants will submit urine, saliva and blood samples; pancreatitis and pancreatic cancer patients will also submit tissue samples if biopsy/ies or surgery is part of the care being provided by their doctor. In partnership with Berg Health, LLC, biomarkers will be investigated for potential use in early detection of pancreatic cancer, to determine prognosis of patients, and to find the most appropriate treatments for patients.

clinicaltrials.gov ↗

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

A. James Moser, MD
Beth Israel Deaconess Medical Center, Harvard University
Principal Investigator
clinicaltrials.gov ↗
Tomislav Dragovich, MD
Banner Health - MD Anderson Cancer Center
Principal Investigator
clinicaltrials.gov ↗

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

6 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

United States

Banner Health - Md Anderson Cancer Center
Gilbert, Arizona, United States
Mayo Clinic - Arizona
Phoenix, Arizona, United States
Beth Israel Deaconess Medical Center
Boston, Massachusetts, United States
Mercy Health - St. Mary'S
Grand Rapids, Michigan, United States
Virginia Piper Cancer Institute - Allina Health
Minneapolis, Minnesota, United States
Washington University School of Medicine
St Louis, Missouri, United States

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

No drug or biological interventions are in our data for this study. It may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start: 31 Mar 2016
Primary completion: 28 Feb 2022
Completion: 28 Feb 2022
Last update posted: 16 Apr 2019
Registered enrollment: 436
Registry id: NCT02781012

clinicaltrials.gov ↗

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 24 Aug 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.